EDGAR Filing Documents for 0001104659-13-049024

Form 8-K - Current report:

SEC Accession No. 0001104659-13-049024

Filing Date

2013-06-13

Accepted

2013-06-13 16:30:23

Documents

Period of Report

2013-06-10

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a13-14876_18k.htm	8-K	59790
2	EX-10.1	a13-14876_1ex10d1.htm	EX-10.1	663171
3	EX-10.2	a13-14876_1ex10d2.htm	EX-10.2	97399
4	GRAPHIC	g148761kg17i001.gif	GRAPHIC	37356
5	GRAPHIC	g148761kg17i002.jpg	GRAPHIC	94614
6	GRAPHIC	g148761kg17i003.jpg	GRAPHIC	93501
7	GRAPHIC	g148761kg17i004.jpg	GRAPHIC	87356
8	GRAPHIC	g148761kg17i005.jpg	GRAPHIC	95280
9	GRAPHIC	g148761kg17i006.jpg	GRAPHIC	86527
10	GRAPHIC	g148761kg17i007.jpg	GRAPHIC	20280
11	GRAPHIC	g148761kg23i001.gif	GRAPHIC	134760
12	GRAPHIC	g148761kg23i002.gif	GRAPHIC	87972
13	GRAPHIC	g148761kg25i001.jpg	GRAPHIC	96443
14	GRAPHIC	g148761kg19i001.jpg	GRAPHIC	77164
	Complete submission text file	0001104659-13-049024.txt		2078864

Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02421

Business Address 100 HAYDEN AVENUE LEXINGTON MA 02421 6174983300

AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)